Titan Pharmaceuticals titanpharm.com


Public lists: Pharma Startups (4743)

Titan Pharmaceuticals, Inc. (AMEX: TTP) is focused on the late-stage development and commercialization of innovative treatments for central nervous system disorders including schizophrenia, opioid addiction, Parkinson's Disease and chronic pain. Titan has established strategic partnerships with leading pharmaceutical companies, including Vanda and Bayer Schering, to advance some of these programs. For more information, please visit the Company's website at www.titanpharm.com.

Titan Pharmaceuticals, Inc. (AMEX: TTP) is focused on the late-stage development and commercialization of innovative treatments for central nervous system disorders including schizophrenia, opioid addiction, Parkinson's Disease and chronic pain. Tita...Show all

Company (IPO / Went public)

Phone: 650-244-4990

Fax:

400 Oyster Point Boulevard
Suite 505
South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Titan Pharmaceuticals $51.1M Mar 23, 2007
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Titan Pharmaceuticals Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Innoviva

Brisbane, California, United States
IPO / Went publicInnoviva, formerly known as Theravance, is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA and ANORO ELLIPTA, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible...Show allLogin to see details

Orexigen Therapeutics

La Jolla, California, United States
Assets PurchasedOrexigen Therapeutics, based in San Diego, California, is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system (CNS), disorders, with an initial focus on obesity. The Company combines individual generic drugs that have previously received regulatory approval for other indications and, thus, have established post-marketing safety records. It screens these drugs for synergistic CNS activity and combines them into ne...Show allLogin to see details
See all 16 competitors